What is the appropriate management of purpura fulminans caused by Neisseria meningitidis?

Management of Purpura Fulminans from Neisseria meningitidis

Immediately initiate IV ceftriaxone 2 g every 12 hours or cefotaxime 2 g every 6 hours as soon as purpura fulminans is suspected, along with aggressive resuscitation for septic shock. 1

Antibiotic Therapy

First-Line Treatment

• Ceftriaxone 2 g IV every 12 hours OR Cefotaxime 2 g IV every 6 hours 1
• Alternative: Benzylpenicillin 2.4 g IV every 4 hours (if organism confirmed susceptible) 1
• For penicillin/cephalosporin allergy: Chloramphenicol 25 mg/kg IV every 6 hours 1

Duration

• 5 days total if patient has recovered 1
• Treatment may need extension if patient not responding 1

Critical Adjunct

• If ceftriaxone was NOT used for treatment, give a single dose of ciprofloxacin 500 mg orally to eliminate nasopharyngeal carriage 1
  • This is essential because only ceftriaxone reliably eradicates meningococcal throat carriage 1
  • If ciprofloxacin contraindicated: rifampicin 600 mg twice daily for 2 days 1

Immediate Resuscitation and Supportive Care

Shock Management

Purpura fulminans represents meningococcal septic shock requiring:

• Aggressive fluid resuscitation 2, 3, 4
• Vasopressor/inotropic support as needed 2, 3
• Correction of hypoglycemia (particularly in infants) and hypocalcemia 3
• Ventilatory support if required 2

Coagulopathy Management

The central pathophysiology involves acquired protein C deficiency leading to microvascular thrombosis 4. However:

• Protein C replacement has limited evidence (used in only 9% of cases historically) 2
• Antithrombin, tissue plasminogen activator, and vasodilator infusions have no proven efficacy 3
• Focus on treating underlying infection and supporting hemodynamics

Surgical Considerations

Early Fasciotomy

• Consider early fasciotomy during initial management 2
• In one series, fasciotomies performed early appeared to limit the level of amputation in 6 of 14 patients (43%) 2
• May reduce depth of soft-tissue involvement and extent of required amputations 2

Debridement and Reconstruction

• Full-thickness skin and soft-tissue necrosis is extensive in purpura fulminans 2
• 90% of patients require skin grafting and/or amputations 2
• 25% require amputations of all extremities 2
• Surgical intervention should be delayed until clear demarcation of viable versus necrotic tissue

Adjunctive Therapies

Corticosteroids

• Historically used in 38% of cases 2
• May have benefit in immune-complex mediated tissue necrosis 5
• One case report showed fever subsidence and clinical improvement with pulsed IV methylprednisolone 5
• Not routinely recommended but consider in refractory cases with strong immune-mediated component

Hyperbaric Oxygen Therapy

• Emerging evidence suggests potential limb-salvage benefit 6
• One recent case demonstrated limb preservation after multiple hyperbaric oxygen sessions 6
• Consider in centers with availability, particularly for limb-threatening ischemia

Critical Pitfalls to Avoid

1. Delayed antibiotic administration: Give antibiotics immediately upon suspicion—even a single ecchymosis with signs of infection warrants treatment 3

2. Underestimating shock in children: Recognition of shock is difficult in pediatric patients; maintain high index of suspicion 3

3. False reassurance from initial stability: Purpura fulminans can develop "impressively over a few minutes" even with stable hemodynamics initially 4. Maintain vigilance even after successful early resuscitation 4

4. Forgetting carriage eradication: If cefotaxime or benzylpenicillin used instead of ceftriaxone, must give ciprofloxacin for throat carriage 1

5. Delaying ICU transfer: All patients with purpura fulminans should be managed in intensive care 3

Prognosis

• Mortality rate: 20-40% despite optimal treatment 3, 7
• 5-20% of survivors require skin grafts and/or amputations 3
• Extensive tissue loss common, with 90% requiring surgical intervention 2
• Early recognition and immediate antibiotic therapy (ideally pre-hospital) reduces mortality (OR 0.36) 3

Public Health Measures

• Immediately notify public health authorities for chemoprophylaxis of close contacts 3
• Case highlights importance of meningococcal vaccination, particularly for unvaccinated young adults 8